AA

Arctic Aurora LifeScience

Europe, Stockholms Lan, Sweden, Stockholm

Description

Arctic Aurora LifeScience provides and offers funding to companies from the healthcare industry.

Investor Profile

Arctic Aurora LifeScience has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series C (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Arctic Aurora LifeScience frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 1
CLI Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Ally Bridge Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Deerfield
North America, New York, United States, New York
Co-Investments: 1
Aju IB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Yeoksamdong
Co-Investments: 1
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 1

Which angels does Arctic Aurora LifeScience often collaborate with?

Daphne Teo
Asia, Singapore
Shared Deals: 1

What are some of recent deals done by Arctic Aurora LifeScience?

Synlogic

Cambridge, Massachusetts, United States

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

BiotechnologyHealth CareTherapeutics
Series CMay 16, 2017
Amount Raised: $42,000,000